Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Basal Cell Nevus Syndrome 2 Skin Neoplasms 1 Carcinoma, Basal Cell 1

Interventions

aldesleukin 9 Interleukin-2 9 Nivolumab 7 fludarabine phosphate 6 Dacarbazine 6 Cyclophosphamide 6 fludarabine 5 Temozolomide 4 Ipilimumab 4 Fluorouracil 4 montanide ISA 51 3 Surveys and Questionnaires 3 Semaxinib 3 Radiotherapy 3 Radiation 3 Mohs Surgery 3 Educational Status 3 Cisplatin 3 Allovectin-7 3 zanolimumab 2 talabostat 2 sonidegib 2 poly ICLC 2 binimetinib 2 Whole-Body Irradiation 2 Vinblastine 2 Vemurafenib 2 Tacrolimus 2 Tablets 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Skin Neoplasms × gusacitinib × Clear all

NCT02550678 2018-06-06

ASN-002-001

Ascend Biopharmaceuticals Ltd

Phase 1/2 Completed

Basal Cell Nevus Syndrome, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡